×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [28]
上海大学 [25]
中国医学科学院 北... [11]
江苏大学 [10]
吉林大学白求恩第一医... [6]
兰州大学 [4]
更多...
内容类型
期刊论文 [91]
会议论文 [8]
专利 [2]
发表日期
2021 [1]
2019 [4]
2018 [16]
2017 [4]
2016 [21]
2015 [17]
更多...
学科主题
Science & ... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共101条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9
作者:
Chen, Xiaofeng
;
Wang, Deqiang
;
Liu, Jing
;
Qiu, Jingrong
;
Zhou, Jun
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2022/01/10
immunotherapy
tumor microenvironment
biomarkers
tumor
genetic markers
A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer
期刊论文
JOURNAL OF THORACIC DISEASE, 2019, 卷号: 11, 期号: 8
作者:
Yang, Yunpeng
;
Chang, Jianhua
;
Huang, Cheng
;
Zhang, Yiping
;
Wang, Jie
收藏
  |  
浏览/下载:85/0
  |  
提交时间:2019/12/05
Non-small cell lung cancer (NSCLC)
oral vinorelbine (oral VRL)
intravenous vinorelbine (intravenous VRL)
cisplatin (CDDP)
Chinese patients
Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9
作者:
Ye, Suofu
;
Chen, Xiaofeng
;
YiYao
;
Li, Yueqin
;
Sun, Ruoxuan
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2019/12/05
A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 6, 页码: 1550-1559
作者:
Zhang, Huo[1]
;
Zhu, Mingxia[2]
;
Du, Yiping[3]
;
Zhang, Hui[4]
;
Zhang, Qing[5]
收藏
  |  
浏览/下载:77/0
  |  
提交时间:2019/12/24
pancreatic adenocarcinoma
lncRNA
biomarker
prognosis
TCGA
Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy
期刊论文
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 卷号: 28, 期号: 1, 页码: 163-173
作者:
Yuwen, Daolu[1]
;
Ma, Yuzhu[2]
;
Wang, Deqiang[3]
;
Gao, Jian[4]
;
Li, Xin[5]
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/24
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Xu, Nong
;
Shen, Lin
;
Dai, Guanghai
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
期刊论文
GASTRIC CANCER, 2018, 卷号: 21, 期号: 5
作者:
Shu, Yongqian
;
Lu, Zhihao
;
Zhang, Xiaotian
;
Liu, Wei
;
Liu, Tianshu
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
Stomach neoplasms
Paclitaxel
Capecitabine
Cisplatin
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
期刊论文
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 卷号: 319, 期号: 24
作者:
Cheng, Ying
;
Li, Jin
;
Qin, Shukui
;
Xu, Rui-Hua
;
Shen, Lin
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Shi, Jianhua
;
Feng, Ji Feng
;
Shen, Lin
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:
Ouyang, Xuenong
;
Shi, Meiqi
;
Jie, Fangwei
;
Bai, Yuxian
;
Shen, Peng
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/12/05
Phase III
Dulanermin
NSCLC
Progression-free survival
Objective response rate
©版权所有 ©2017 CSpace - Powered by
CSpace